Amarantus Bioscience Holdings Inc (AMBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,214 | -27,277 | -15,132 | -5,136 | -4,440 |
| Depreciation Amortization | 1,656 | 958 | 2,091 | 676 | 15 |
| Accounts payable and accrued liabilities | 1,469 | 4,645 | 88 | 1,184 | 1,059 |
| Other Working Capital | 1,551 | 4,361 | 1,009 | 1,095 | 754 |
| Other Operating Activity | 4,524 | 5,982 | 8,471 | 1,026 | -203 |
| Operating Cash Flow | $-16,014 | $-11,331 | $-3,473 | $-1,154 | $-2,816 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -50 | N/A | N/A | N/A |
| PPE Investments | -10 | -181 | N/A | N/A | -5 |
| Net Acquisitions | -900 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -4,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -4,000 | -1,304 | -70 | -56 | 0 |
| Investing Cash Flow | $-4,910 | $-1,535 | $-70 | $-56 | $-5 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 3,075 | N/A | N/A | N/A | N/A |
| Debt Issued | 4,605 | 500 | 5,048 | 1,413 | 805 |
| Debt Repayment | -105 | -9 | -304 | -47 | N/A |
| Common Stock Issued | 2,883 | 8,049 | N/A | N/A | 1,995 |
| Other Financing Activity | 10,428 | 3,507 | -325 | 0 | -26 |
| Financing Cash Flow | $20,886 | $12,047 | $4,419 | $1,366 | $2,774 |
| Beginning Cash Position | 214 | 1,033 | 157 | 1 | 48 |
| End Cash Position | 176 | 214 | 1,033 | 157 | 1 |
| Net Cash Flow | $-38 | $-819 | $876 | $156 | $-47 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,014 | -11,331 | -3,473 | -1,154 | -2,816 |
| Capital Expenditure | -10 | -181 | N/A | N/A | -5 |
| Free Cash Flow | -16,024 | -11,512 | -3,473 | -1,154 | -2,820 |